Information Journal Paper
APA:
CopySHANEHBANDI, D., MAJIDI, J., & KAZEMI, T.. (2017). CD20-BASED IMMUNOTHERAPY OF B-CELL DERIVED HEMATOLOGIC MALIGNANCIES. CURRENT CANCER DRUG TARGETS, 17(5), 423-444. SID. https://sid.ir/paper/720508/en
Vancouver:
CopySHANEHBANDI D., MAJIDI J., KAZEMI T.. CD20-BASED IMMUNOTHERAPY OF B-CELL DERIVED HEMATOLOGIC MALIGNANCIES. CURRENT CANCER DRUG TARGETS[Internet]. 2017;17(5):423-444. Available from: https://sid.ir/paper/720508/en
IEEE:
CopyD. SHANEHBANDI, J. MAJIDI, and T. KAZEMI, “CD20-BASED IMMUNOTHERAPY OF B-CELL DERIVED HEMATOLOGIC MALIGNANCIES,” CURRENT CANCER DRUG TARGETS, vol. 17, no. 5, pp. 423–444, 2017, [Online]. Available: https://sid.ir/paper/720508/en